Home
Home
News Feed
Free Newsletters
Medical News 'Tweets'
Talk Medical
News A-Z
Business / Finance
Child Health News
Device / Technology News
Disease/Infection News
Drug Trial News
Healthcare News
Medical Condition News
Medical Patent News
Medical Procedure News
Medical Research News
Medical Science News
Men's Health News
Miscellaneous News
Pharmaceutical News
Women's Health News
Alzheimer's
Arthritis
Asthma
Autism
Blood Pressure
Breast Cancer
Cancer
Cardiovascular Disease
Cellulitis
Cerebral Palsy
CLL
Cirrhosis
Crohn's Disease
Cystic Fibrosis
Depression
Diabetes
Diet
Eczema
Erectile Dysfunction
Fibromyalgia
Genetics
Glioblastoma
Gout
H1N1
H3N2
Hearing Loss
Heart Attack
Hepatitis
Herpes
HIVAIDS
Huntington's Disease
IVF
Lou Gehrig' Disease
Macular Degeneration
Mental Health
Multiple Sclerosis
Neurology
Nutrition
Obesity
Osteoarthritis
Pancreatic Cancer
Parkinson's Disease
Pneumonia
Pregnancy
Prostate Cancer
Retinitis Pigmentosa
Rheumatoid Arthritis
Schizophrenia
Sleep Apnea
Stem Cell
Stroke
Ulcerative Colitis
Vaccine
Virus
Health A-Z
Acne
Alzheimer's Disease
Antioxidant
Arthritis
Asthma
Atrial Fibrillation
Autism
Back Pain
Bipolar Disorder
Breast Cancer
Breastfeeding
Cancer
Cerebral Palsy
Cervical Cancer
Colon Cancer
Cystic Fibrosis
Dementia
Diabetes
Eating Disorder
Eczema
Epilepsy
Fibromyalgia
Folic Acid
Genetics
Glaucoma
Gout
Heart Attack
HIV/AIDS
Hypertension
Immunology
Impotence
Kidney Cancer
Leukemia
Lung Cancer
Malaria
Measles
Menopause
Obesity
Osteoporosis
Ovarian Cancer
Parkinson's Disease
Pediatrics
Prostate Cancer
Retinitis Pigmentosa
Rosacea
Schizophrenia
Skin Cancer
Stem Cell
Tuberculosis
Virus
West Nile Virus
Drugs A-Z
Abilify
Actilyse
Akamin
Amoxil Adult Preparations
Andriol Testocaps
Apo-Amlodipine
Apo-Atenolol
Apo-Clarithromycin
Apo-Clopidogrel
Apo-Gabapentin
Apo-Lansoprazole
Apo-Lisinopril
Apo-Omeprazole
APO-Oxazepam
Apo-Paracetamol Codeine
Apo-Tramadol SR
Arcoxia
Augmentin Syrup
Avil
Avomine
Bactrim
Bactroban Ointment
Bicor
Brufen
Buscopan Tablets
Clexane
Concerta
Coveram
Coversyl
Creon 10000; 25000; and 40000
Daonil
Dilatrend
Duodart
Dynastat
Epilim
Flagyl
Largactil
Lexotan
Lignocaine Injection
Loette
Metrogyl
Monofeme
Motilium
Nausetil
Norgesic
Noriday
Norspan
Norvasc
Nurofen 400 Double Strength
OxyContin
Panadol Cold & Flu Relief Original Formula
Rivotril
Serc
Stemetil
Stieva-A
Telfast
Valium
Voltaren
Zinnat
Zyprexa
Health Products
Autoclaves
Benchtop Sterilizers
Blood Gas Analyzers
Blood Glucose Monitors
Blood Pressure Monitors
CT Scanners
Defibrillators
DNA Sequencing / Analysis Systems
ECG Machines
Fetal Monitors
Fluorometers
Heart Rate Monitors
Hematology Blood Analyzers
Mammography Systems
MRI Scanners
Otoscopes / Auriscopes
Pregnancy Tests
Pulse Oximeters
Spirometers
Stethoscopes
Ultrasound Machines
Vital Signs Monitors
Health Services
Gastric Banding
Hair Transplantation
IVF Clinics
Lasik Eye Surgery
Liposuction
Australian Health Insurance
Canadian Health Insurance
U.S. Health Insurance
UK Health Insurance
News Archive
Info / About
Terms and Conditions
Medical News Letters
Free Magazines
May 27, 2012
Other search tools:
Drugs
|
Health
|
News
About
Terms
Latest News
New, more accurate test for paralytic shellfish poisons
Study: 10 percent of veterans go without health insurance
Muslim women, religious leaders being enlisted in global campaign to eradicate polio
Mass. hospital agrees to $750,000 settlement over 2010 data breach
Overactive BAALC gene found in people with acute leukemia
Senate Appropriations Committee approves FY13 state and foreign operations appropriations bill
Research roundup: Do mandatory screening laws affect disparities?; Mass. health law, 6 years later
Illinois legislature passes bill with deep Medicaid cuts
Special surface allows adult-derived stem cells to thrive and transform into multiple cell types
IPS reports on population and development conference draft declaration
Biotechnology
Blood Pressure
Bone
Brain
Breast Cancer
Cancer
Cell
Chemotherapy
Depression
Diabetes
Diagnostics
Diet
DNA
Education
Exercise
Gene
Genetics
Health and Human Services
Health Insurance
HIV
Hospital
Investment
Medicaid
Medicare
Muscle
Neurology
Neuroscience
Nursing
Nutrition
Obesity
Oncology
Pain
Placebo
Pregnancy
Prostate Cancer
Protein
Stress
Stroke
Translational
Vaccine
Read in |
English
|
Español
|
Français
|
Deutsch
|
Português
|
Italiano
|
日本語
|
한국어
|
简体中文
|
繁體中文
|
العربية
|
Dansk
|
Nederlands
|
Filipino
|
Finnish
|
Ελληνικά
|
עִבְרִית
|
हिन्दी
|
Bahasa
|
Norsk
|
Русский
|
Svenska
|
Magyar
|
Polski
| Română |
Türkçe
Lupus fapte
Tweet
Lupus este un boli cronice autoimune, care provoacă inflamarea diferite părţi ale corpului, în special pielii, articulaţiilor şi rinichi. Se pot de asemenea afecta sânge. În mod normal, sistemul imunitar protejează corpului împotriva virusuri, bacterii şi altor invadatori străin. Într-o boală autoimună ca lupus, sistemul imunitar pierde capacitatea sa de a spune diferenţa între substanțe străine şi propriile sale celule şi ţesuturi. Sistemul imunitar face apoi anticorpi îndreptate împotriva organismul de sine.
Lupus nu este infecţioase, rare sau canceroase.
Deşi cauza lupus este necunoscut, oamenii de ştiinţă bănuiţi că indivizii sunt genetic predispuşi la lupus, şi, de asemenea, ştiu că factorii de mediu, cum ar fi infecţii, antibiotice, lumină ultravioletă, extreme de stres şi anumite medicamente joacă un rol critic în declanşarea lupus.
Lupus greve femeile adulte 10-15 ori mai frecvent decât bărbaţi adulţi.
Lupus este mai răspândit în afro-americani, Hispanics şi asiatici. African American femeile sunt trei ori mai multe şanse pentru a obţine lupus decat femeile caucaziene. Atât afro-americani şi Hispanics/latine tind să dezvolte lupus la o vârstă mai tânără şi au mai multe simptome la diagnosticul (inclusiv probleme renale).
10% Din oameni cu lupus va avea o ruda (mamă sau frate) care are sau poate dezvolta lupus. Doar aproximativ 5% din copiii născuţi persoanelor cu lupus va dezvolta boala.
Uneori oamenii cu lupus experienţa unei refracţii"." Acest lucru se întâmplă atunci când unele simptome apar pentru perioade scurte de timp, apoi dispar. Chiar dacă luaţi medicamente pentru lupus, aţi putea descoperi că există momente când simptomele devin mai rău. Învăţare să recunoască faptul că unei refracţii provine vă poate ajuta să ia măsuri pentru a face faţă cu ea. Mulţi oameni simt foarte obosit sau au durere, o erupţie, febră, stomac disconfort, dureri de cap sau ameţeli chiar înainte de a unei refracţii....
Lupus poate fi dificil pentru a diagnostica ca simptomele veni şi du-te şi imite cele din multe alte boli. Unele simptome de lupus poate fi tranzitorii cum ar fi comune şi muşchi durere, oboseala, o erupţie cauzate sau făcute mai rău de lumina soarelui, febre ușoară, căderea părului, pleurezie, pierderea poftei de mâncare, dureri în nasul sau gura sau sensibilitatea dureros de degetele în medii rece.
Simptome de lupus poate varia de la uşoară la viaţa în pericol şi mii de americani die de lupus complicaţii în fiecare an.
Cu grijă optimă, cele mai multe femei cu lupus pot avea copii sănătoşi fără a periclita sănătatea lor proprii.
Lecturi suplimentare
Ce este Lupus?
Simptome de lupus
Diagnosticul de lupus
Torțe de lupus
Tratamente lupus
Lupus şi sarcinii
Lupus şi stres
Recent Lupus News
LabCorp, XDx partner to develop and commercialize SLE flare predictor test
XDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp)whereby each party will collaborate in marker discover...
Severe hypersensitivity reactions to anti-HIV drug occur through autoimmune mechanism
Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body'...
Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitis
New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI (golimumab) induced clinical response in a majority of patien...
Ipsen, Active Biotech complete half of planned recruitment in tasquinimod phase III study for CRPC
Active Biotech and Ipsen today announced that recruitment to the global, pivotal, randomized, double-blind, placebo-controlled phase III study of tasquinimod in patients with metastatic castrate-resis...
Ipsen, Active Biotech to present data from tasquinimod phase II trial on CRPC at ASCO 2012
Active Biotech and Ipsen will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference "2012 ASCO Annual Meeting" to be held in Chicago (USA) on 1-5 June 2012.